Caliber Imaging & Diagnostics’ VivaScope System Receives ‘Product of the Year 2013’ Award from German Journal Aesthetic Dermatology

VivaScope ‘Enables Comprehensive Diagnostics of the Highest Degree’ 

BOSTON and ROCHESTER, NY – April 9, 2014 — Caliber Imaging & Diagnostics (OTCQB: LCDX), formerly Lucid, Inc., has received the “Product of the Year 2013” Award from the German journal Aesthetic Dermatology for its VivaScope® system.

Continue reading

Posted in Uncategorized | Comments Off

Caliber Imaging & Diagnostics Appoints Joseph R. Williams as Its First Vice President of Global Marketing

More Than 30 Years of Healthcare Marketing Experience Strengthens Company 

BOSTON and ROCHESTER, NY – March 26, 2014 — Caliber Imaging & Diagnostics (OTCQB: LCDX), formerly Lucid, Inc., has appointed Joseph R. Williams as Vice President of Global Marketing, a newly created position, effective immediately.

Continue reading

Posted in Uncategorized | Comments Off

Caliber Imaging & Diagnostics Names Richard C. Christopher to Chief Financial Officer

Former CFO of DUSA Pharmaceuticals Provides Financial and Industry Strength to Executive Management Team 

BOSTON and ROCHESTER, NY — March 20, 2014 — Caliber Imaging & Diagnostics (OTCQB: LCDX), formerly Lucid, Inc., has named Richard C. Christopher as Chief Financial Officer, effective immediately. Mr. Christopher replaces Richard J. Pulsifer.

Continue reading

Posted in Uncategorized | Comments Off

Caliber Imaging & Diagnostics Names Daniel Koon to Director of Global Sales Support

BOSTON and ROCHESTER, NY – March 13, 2014 — Caliber Imaging & Diagnostics (OTCQB: LCDX), formerly Lucid, Inc., has named Daniel Koon to Director of Global Sales Support, effective immediately. Mr. Koon most recently served as Caliber I.D.’s Research Sales Manager, and prior to that held other positions within the company.

Continue reading

Posted in Uncategorized | Comments Off

Caliber Imaging & Diagnostics Names Anthony J. Roberto as Sales Manager for East Coast

Industry Veteran to Enhance Company VivaScope® Initiatives in This Newly Created Position

BOSTON and ROCHESTER, N.Y., March 10, 2014 (GLOBE NEWSWIRE) — Caliber Imaging & Diagnostics (OTCQB:LCDX), formerly Lucid, Inc., has named Anthony J. Roberto as East Coast Sales Manager, a newly created position. He will be focused on further developing the Company’s sales initiatives for its VivaScope® platform in the East Coast region of the United States.

Continue reading

Posted in Uncategorized | Comments Off

Caliber Imaging & Diagnostics Names Robert T. Kelley to Vice President of U.S. Sales

BOSTON and ROCHESTER, NY – March 5, 2014 — Caliber Imaging & Diagnostics (OTCQB: LCDX), formerly Lucid, Inc., has named Robert T. Kelley to Vice President of U.S. Sales, effective immediately. Mr. Kelley had served as Caliber I.D.’s Director of Clinical Sales since joining the company in November 2011.

Continue reading

Posted in Uncategorized | Comments Off

Caliber Imaging & Diagnostics Receives $1.4 Million Order for VivaScope® Systems from European Distributor MAVIG GmbH

Expects to Deliver Devices in the First Half of 2014

BOSTON and ROCHESTER, N.Y. – January 14, 2014 – Caliber Imaging & Diagnostics (OTCQB: LCDX), formerly Lucid, Inc., announces receipt of $1.4 million in orders for VivaScope® systems from its European distributor MAVIG GmbH. These units are scheduled to be shipped in the first half of 2014. MAVIG has been Caliber’s exclusive distributor in Europe for the past eight years.

Continue reading

Posted in Uncategorized | Comments Off

Caliber Imaging & Diagnostics Appoints Daniel Mark Siegel, M.D. to Its Board of Directors

Dermatologist with 25 Years of Experience Expands the Board to Eight Directors 

ROCHESTER, N.Y. and BOSTON — January 13, 2014 – Caliber Imaging & Diagnostics (OTCQB: LCDX), formerly Lucid, Inc., announces the appointment of Daniel Mark Siegel, M.D. to its Board of Directors, effective immediately. This increases the number of Board members to eight.

Continue reading

Posted in Uncategorized | Comments Off

Caliber Imaging & Diagnostics to Exhibit Poster at Society of Cosmetic Chemists Annual Scientific Meeting & Technology Showcase December 12 – 13 in NYC

VivaScope Provides Distinct Advantages To Cosmetic Industry by Substantiating Claims and Shortening Product-Development Cycle

ROCHESTER, NY and BOSTON – December 2, 2013 — Caliber Imaging & Diagnostics (OTCQB: LCDX), formerly Lucid, Inc., will exhibit a poster on confocal microscopy at the Society of Cosmetic Chemists 2013 Annual Scientific Meeting and Technology Showcase, to be held December 12-13 in New York, NY.

Continue reading

Posted in Uncategorized | Comments Off

Caliber Imaging & Diagnostics Appoints Robert P. Fischmann as VP of Operations, a Newly Created Position

More Than Three Decades of Experience Will Guide Company’s Operations

BOSTON and ROCHESTER, NY – November 25, 2013 — Caliber Imaging & Diagnostics (OTCQB: LCDX), formerly Lucid, Inc., has appointed Robert P. Fischmann to the role of Vice President of Operations, a newly created position.

L. Michael Hone, Chief Executive Officer of Caliber I.D., said, “As we prepare for the anticipated growth of our company, we have reached the point where we will benefit from the expertise of an experienced, seasoned operations professional. I am honored that Robert Fischmann, with his substantial global and domestic experience, has accepted this role. Robert will report directly to me, and I am confident he will excel in overseeing the direction, strategy, planning and execution of our manufacturing operations activities.”

Continue reading

Posted in Uncategorized | Comments Off

Caliber Imaging & Diagnostics Appoints Steven M. Ridge and Ben J. Alexander as Regional Sales Managers for West and Midwest

Industry Veterans To Enhance Company VivaScope® Sales Initiatives in These Newly Created Positions

BOSTON and ROCHESTER, NY – November 20, 2013 — Caliber Imaging & Diagnostics (OTCQB: LCDX), formerly Lucid, Inc., has appointed Steven M. Ridge as Midwestern Regional Sales Manager and Ben J. Alexander as Western Regional Sales Manager, both newly created positions. Each will be focused on further developing the Company’s sales initiatives for its VivaScope® platform in the West and Midwest regions of the United States. The FDA-cleared VivaScope® devices provide patients the option of a painless, noninvasive optical skin biopsy in lieu of expensive and painful traditional skin biopsy while also having potential applications in several other medical and research specialties.

Continue reading

Posted in Uncategorized | Comments Off

Caliber Imaging & Diagnostics Reports Third Quarter 2013 Results

BOSTON and ROCHESTER, NY – November 11, 2013 — Caliber Imaging & Diagnostics (OTCQB: LCDX), formerly Lucid, Inc., has released its financial results for the third quarter ended September 30, 2013. The Company has filed its Form 10-Q for the period ending September 30, 2013 which can be found on the Securities and Exchange Commission’s website at www.sec.gov.

Continue reading

Posted in Uncategorized | Comments Off

Caliber Imaging & Diagnostics’ VivaScope System Featured on Fox News

Video Segment and Article Spotlight Advantages of Noninvasive Biopsies  

BOSTON and ROCHESTER, NY – November 4, 2013 – The VivaScope® cellular imaging system developed by Caliber Imaging & Diagnostics (OTCQB: LCDX), formerly Lucid, Inc., was featured in a video segment and article posted on Fox News on October 29. VivaScope allows doctors to offer their patients noninvasive optical biopsies of skin and to aid in the detection of skin cancer. Since there is no cutting, there is also no possibility of infection or scarring.

The segment and article, titled “New technology performs skin biopsies without the cutting,” note the benefits of noninvasive biopsy, and report that confocal microscopy has moved beyond the research stage and is being used to help physicians to diagnose patients quickly and painlessly. The segment and article also profile Dr. Babar Rao, director of Rao Dermatology in New York City, who notes that a scan of a lesion can be obtained within several minutes, and the images can be magnified to look for abnormal cells. The segment and article also depict VivaScope’s use in examining a lesion on a three-year-old female patient. Furthermore, Dr. Rao remarks that the procedure is ideal if the patient has a mole on their face or breast, and expresses a hope that confocal microscopy will become “the x-ray of dermatology.”

Continue reading

Posted in Uncategorized | Comments Off

Caliber Imaging & Diagnostics to Raise Capital

BOSTON and ROCHESTER, NY– October 28, 2013 — Caliber Imaging & Diagnostics (OTCQB: LCDX) formerly Lucid, Inc., plans to raise capital through a general solicitation with H.C. Wainwright & Co., LLC acting as placement agent. The offering will only be open to accredited investors and is described in an offering memorandum available on Caliber I.D.’s website at www.caliberid.com/offering-memorandum.html

Continue reading

Posted in Uncategorized | Comments Off

Caliber Imaging & Diagnostics To Exhibit at the 64th American Association for Laboratory Animal Science National Meeting on October 27-31, 2013

Company To Provide Live Demonstrations of VivaScope 1500 Multilaser and

VivaScope 3000 Portable Handheld Confocal Microscope

BOSTON and ROCHESTER, NY – October 25, 2013 — Caliber Imaging & Diagnostics (OTCQB: LCDX), formerly Lucid, Inc., is exhibiting at the 64th American Association for Laboratory Animal Science National Meeting on October 27-31 in Baltimore, Maryland. The Company’s exhibit will be located at Booth #2120. Continue reading

Posted in Uncategorized | Comments Off

Caliber Imaging & Diagnostics Featured in Boston Globe

Article Spotlights Ability of VivaScope System to Perform Noninvasive Biopsies

BOSTON and ROCHESTER, NY– October 21, 2013 — Caliber Imaging & Diagnostics (OTCQB: LCDX) formerly Lucid, Inc., was featured in an article in the Boston Globe on October 14.

The article, titled “Laser imaging device makes no-cut biopsies possible,” focuses on Caliber’s VivaScope® devices and their success in enabling doctors to perform biopsies without cutting into skin and to determine relatively quickly if a patient has cancer. The article also briefly details VivaScope’s rollout to hospitals and the Company’s efforts to spur wider adoption of the devices. Continue reading

Posted in Uncategorized | Comments Off

Caliber Imaging & Diagnostics’ VivaScope System To Be Featured at 1st Latin American Congress of Dermoscopy on October 17-18, 2013

Company’s Brazilian Distributor Emdutos To Provide Live Demonstrations of 

VivaScope 3000 Portable Handheld Confocal Microscope

ROCHESTER, NY and BOSTON – October 15, 2013 — Caliber Imaging & Diagnostics (OTCQB: LCDX), formerly Lucid, Inc., announced that the Company’s VivaScope® cellular imaging system will be featured at the 1st Latin American Congress of Dermoscopy on October 17-18, 2013 in São Paulo, Brazil. The FDA-cleared VivaScopedevices provide patients the option of a painless, noninvasive optical skin biopsy in lieu of expensive and painful traditional skin biopsy while also having potential applications in several other medical and research specialties.

Continue reading

Posted in Uncategorized | Comments Off

Caliber Imaging & Diagnostics to Present at AdvaMed 2013: The MedTech Conference on September 24, 2013

CEO Michael Hone to Discuss VivaScope® Technology and Corporate Growth Strategy 

ROCHESTER, NY and BOSTON, MA — September 20, 2013  – Caliber Imaging & Diagnostics (OTCQB: LCDX), formerly Lucid, Inc., is presenting at the AdvaMed 2013: The MedTech Conference on September 24, 2013 at 9:45 AM EDT in Washington, DC.

L. Michael Hone, Chief Executive Officer of Caliber I.D., will describe the Company’s platform of VivaScope® confocal microscopes. The FDA-cleared VivaScope® cellular imaging devices provide patients the option of a painless, noninvasive optical skin biopsy in lieu of expensive and painful traditional skin biopsy while also having potential applications in several other medical and research specialties. He will discuss the Company’s strategy, markets and growth plans as they relate to cost efficiency in the scope of dermatological and medical care. Continue reading

Posted in Uncategorized | Comments Off

Caliber Imaging & Diagnostics Welcomes Updated European Guideline on Basal Cell Carcinoma That Praises Confocal Microscopy

 Company’s German Distribution Partner MAVIG Expected To Benefit from Guideline 

ROCHESTER, NY and BOSTON, MA — September 16, 2013  – Caliber Imaging & Diagnostics (Caliber I.D.), formerly Lucid, Inc. (OTCQB:LCDX), welcomes the recent update to the Guideline on Basal Cell Carcinoma published by the European Dermatology Forum. The updated guideline identifies confocal microscopy as one of three emerging techniques in digital imaging diagnostics and reports that confocal microscopy “has shown high diagnostic accuracy for the diagnosis of basal cell carcinoma.” Continue reading

Posted in Uncategorized | Comments Off

Caliber Imaging & Diagnostics Introduces VivaScope® 1500 Multilaser System

 Newest VivaScope® Device Provides Imaging Capabilities at Three Specific Wavelengths to Analyze Living Skin 

ROCHESTER, NY and BOSTON, MA– September 10, 2013  – Caliber Imaging & Diagnostics (Caliber I.D.), formerly Lucid, Inc. (LCDX), has introduced the VivaScope® 1500 Multilaser system, the newest device in the company’s VivaScope confocal microscope product line. VivaScope Multilaser cellular imaging devices give researchers the option of a painless, noninvasive optical skin biopsy to study changes at the cellular level. Continue reading

Posted in Uncategorized | Comments Off